Commons Capital


Claros Diagnostics

Claros Diagnostics is a medical device company developing low-cost, rapid, point-of-care diagnostics. Using proprietary chemistry and microfluidic technology from Professor George Whitesides’ lab at Harvard University, the company’s initial product will be a handheld urological cancer diagnostic testing system for point-of-care use. Claros is also exploring ways to use its platform to develop affordable, appropriate diagnostics for global health applications.

Location: Woburn, Massachusetts

Commons Capital’s co-investors include:
Oxford Bioscience Partners, BioVentures Investors and Accelerated Technologies Partners


Healthcare Claros Diagnostics
  CodeRyte, Inc.
  Combinent BioMedical Systems
  HistoRx, Inc.
  Medical Metrix Solutions, Inc.
  Teladoc, Inc.
Energy CTP Hydrogen
  H2Gen Innovations
  Pelamis Wave Power Ltd.
  Protonex, Inc.
Education Apex Learning, Inc.
  OutStart Inc.
Environment Niman Ranch
  Passport Systems, Inc.
  Sun & Earth, Inc.
Other Solstice Capital II LP



  | Home | The Fund | Team | Portfolio | Global Health | News | Contact